Company news

ClearPoint Neuro Inc. news in 2023

ClearPoint Neuro Inc.'s news releases, calls and decks from 2023, newest first.

View company

ClearPoint Neuro Reports Third Quarter 2023 Results

November 8, 2023

ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023

October 25, 2023

ClearPoint Neuro Reports Second Quarter 2023 Results

August 7, 2023

ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023

July 24, 2023

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

May 23, 2023

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

May 17, 2023

ClearPoint Neuro Reports First Quarter 2023 Results

May 10, 2023

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

May 9, 2023

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

April 27, 2023

ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System

April 19, 2023

ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model

April 17, 2023

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

April 12, 2023

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS

April 10, 2023

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

March 27, 2023

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results

February 28, 2023

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023

February 14, 2023

ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue

January 10, 2023

Calls in 2023

Decks in 2023